Protecting Research Subjects — What Must Be Done
Top Cited Papers
- 14 September 2000
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 343 (11) , 808-810
- https://doi.org/10.1056/nejm200009143431112
Abstract
As we race toward the as yet unimagined scientific and medical triumphs of the 21st century, no one is more hopeful about the journey than I am. Nevertheless, moving ahead with cutting-edge research must not mean leaving behind well-established international standards for protecting human subjects in clinical trials. None of these principles is more important than the protection of research subjects by informed consent based on full disclosure of potential risks and benefits.I did not expect, or want, to complete my tenure as secretary of health and human services by raising questions about the safety of patients in clinical . . .Keywords
This publication has 2 references indexed in Scilit:
- Is Academic Medicine for Sale?New England Journal of Medicine, 2000
- Association of American Medical Colleges Council of Teaching Hospitals Spring Meeting: Remarks by Jane E. HenneyPublished by American Psychological Association (APA) ,2000